Parathyroid hormone receptor 1 inverse agonist (National Center for Advancing Translational Sciences)

N/A

Report date: 2025/01/26 15:09:51
NME

Base Information

Drug NameParathyroid hormone receptor 1 inverse agonist (National Center for Advancing Translational Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionParathyroid hormone/parathyroid hormone-related peptide receptor inverse agonists
TargetsParathyroid hormone/parathyroid hormone-related peptide receptor
Therapy Area/IndicationsMetaphyseal dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Advancing Translational Sciences
Inactive CompaniesN/A
Active IndicationsMetaphyseal dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A